↓ Skip to main content

Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First‐Line Treatment for HER‐2‐positive Locally Recurrent or Metastatic Breast Cancer

Overview of attention for article published in Oncologist, March 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
52 Mendeley